Mainz Biomed B.V. (MYNZ)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$0.83
+0.36%
Mkt Cap $3.35M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q3 2025 Sep 26, 2025 | $497.00K | $286.72K | -42.31% | — | -$2.65 | — | — | — |
| Q2 2025 Apr 8, 2025 | — | $373.22K | — | -$3.60 | -$9.60 | -166.67% | — | — |
| Q4 2024 Dec 26, 2024 | $600.00K | $520.77K | -13.20% | -$4.40 | -$15.60 | -254.55% | — | — |
| Q2 2024 Apr 9, 2024 | $220.00K | $214.76K | -2.38% | -$0.32 | -$9.60 | -2900.00% | — | — |
| Q4 2023 Nov 16, 2023 | $250.00K | $500.21K | +100.08% | -$20.00 | -$15.60 | +22.00% | — | — |
| Q2 2023 May 16, 2023 | $266.67K | $251.40K | -5.73% | -$18.80 | -$18.00 | +4.26% | — | — |
| Q4 2022 Nov 2, 2022 | — | $278.48K | — | -$0.43 | -$0.97 | -125.90% | — | — |
| Q2 2022 May 2, 2022 | — | $160.04K | — | — | -$1.30 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | $417.31K | — | — | -$0.02 | — | — | — |
| Q4 2020 Dec 31, 2020 | — | $246.78K | — | — | -$0.01 | — | — | — |
| Q2 2020 Jun 30, 2020 | — | $246.78K | — | — | -$0.01 | — | — | — |
| Q4 2019 Dec 31, 2019 | — | $70.35K | — | — | -$0.02 | — | — | — |
| Q2 2019 Jun 30, 2019 | — | $70.35K | — | — | -$0.02 | — | — | — |